Manuel Ascano
-
Thirteen named 2023 Chancellor Faculty Fellows
Thirteen outstanding faculty members from across the university have been selected for the 2023 cohort of Chancellor Faculty Fellows. The group is composed of highly accomplished, recently tenured faculty from a wide variety of disciplines and areas of expertise. Read MoreJun 7, 2023
-
Lab-to-Table Conversation: ‘Rising Tide–Impact of Climate Change on Human Health’ Dec. 20
How does climate change affect human health? How are animals and ecosystems similarly influenced, and how are these impacts interconnected? Join Charles Sanders, associate dean for research and professor of biochemistry, as he delves into these questions and more during the next Lab-to-Table Conversation from the Vanderbilt University School of Medicine Basic Sciences. Read MoreDec 9, 2022
-
Ask an Expert: What do we know about the future of contagious outbreaks?
Manuel Ascano, assistant professor of biochemistry and pathology, microbiology and immunology, discusses the challenges scientists face when researching which virus may cause the next pandemic. Read MoreAug 24, 2020
-
Probing innate immunity
Manuel Ascano team validates an inhibitor of the cGAS-STING signaling pathway, which is important for cellular innate immunity against bacteria, viruses, and our own damaged DNA. Read MoreMay 19, 2020
-
New method captures early viral-host protein interactions
Researchers have developed a method to identify the primary interactions between incoming viral RNA genomes and host proteins. Read MoreMay 7, 2020
-
Ascano, Zanic named Basic Sciences Dean’s Faculty Fellows
The School of Medicine Basic Sciences has established a new Dean’s Faculty Fellows program designed to recognize the efforts of faculty in the early stages of their careers. Read MoreApr 24, 2020
-
University launches Public Health Advisory Task Force in response to COVID-19
Interim Chancellor and Provost Susan R. Wente has established a new Public Health Advisory Task Force to serve as a resource for the university during the COVID-19 pandemic. Read MoreMar 23, 2020
-
A switch for autoimmunity
Vanderbilt investigators have discovered a class of compounds that inhibit a mediator of inflammation and autoimmune disorders, and that could pave the way for development of future therapies. Read MoreOct 12, 2017
-
Ascano seeks to shed light on cellular stress response
Ebola. Chikungunya. Influenza. What’s to be done about these headline-grabbing, debilitating, often lethal viruses? Read MoreAug 28, 2014